Albert Bourla

Pfizer CEO Albert Bourla Set To Meet Activist Investor Starboard Value As Pressure Mounts To Revitalize Struggling Stock: Report
Palantir, Oracle, Pfizer Chiefs Lobby US Lawmakers For Israel's Support Amid Hamas Attack, Hostage Crisis
Here Are All The Corporate CEOs Who Made A Beeline To China To Chase Huge Market Opportunities Amid The Country's Reopening
Palantir, Oracle, Pfizer Chiefs Lobby US Lawmakers For Israel's Support Amid Hamas Attack, Hostage Crisis
Here Are All The Corporate CEOs Who Made A Beeline To China To Chase Huge Market Opportunities Amid The Country's Reopening
Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines?
Pfizer Is Sending Seagen Stock Soaring Monday: What's Going On?

Albert Bourla Recent News

Why Pfizer Shares Are Rising Today
Pfizer Inc (NYSE: PFE) is trading higher Tuesday after the company announced better-than-expected third-quarter financial results and raised guidance.
Why Cruise Line Stocks Are Riding A Wave Higher Today
Shares of cruise line stocks including Carnival Corp (NYSE: CCL) and Royal Caribbean Group (NYSE: RCL) are trading higher Monday amid reopening optimism as investors weigh vaccine progress and booster shot developments.
Pfizer CEO Says People Needing COVID-19 Vaccines Every Year Is The 'Most Likely Scenario'
Pfizer Inc (NYSE: PFE) CEO Albert Bourla said that there is a likelihood that annual booster shots of the coronavirus vaccine will be needed.
Pfizer Working On Specialized Vaccine Targeting COVID-19 Delta Variant: CEO
Pfizer Inc. (NYSE: PFE) CEO said the company is working on a specialized vaccine targeting the highly contagious delta variant of COVID-19.
Fintech Focus For April 16, 2021
Quote To Start The Day: "Spread love everywhere you go. Let no one ever come to you without leaving happier."
Pfizer CEO Has 'Message Of Hope' On Coronavirus Pandemic Anniversary
Real-world data coming out of Israel shows that Pfizer Inc. (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) COVID-19 vaccine is more than 90% effective in preventing asymp
Securities Lawyer, Market Pros On Pfizer CEO's Stock Sale: 'PR Nightmare'
Pfizer Inc. (NYSE: PFE) CEO Albert Bourla sold more than $5.5 million of his company's stock at nearly the same time the company announced an encouraging
Pfizer CEO Bourla Offloads $5.6M In Stock In Preplanned Sale Amid Vaccine Rally
Pfizer Inc.
Pfizer CEO, Board Member On COVID-19 Vaccine Progress, 'Brief, But Hard Stretch' Ahead
Monday could go down in the history books as "a great day for humanity" after Pfizer Inc. (NYSE: PFE) released encouraging results from its COVID-19 vaccine study, Pfizer CEO Albert Bourla said on
Pfizer CEO Decries Politicization Of COVID-19 Vaccine During Trump-Biden Debate
Pfizer Inc (NYSE: PFE) CEO Albert Bourla decried the politicization of the COVID-19 vaccine in an internal memo on Thursday, CNBC
Gilead, Pfizer, Eli Lilly CEOs On COVID-19 Treatments, Vaccine Development
Major coronavirus treatments and vaccine maker executives were interviewed on CNBC Monday to discuss their company's progress in the battle against the disease.
Pfizer To Charge $39 Per Coronavirus Vaccine Course To All Developed Countries For Similar Volume Commitments As US
Pfizer Inc. (NYSE: PFE) would not give a discount to any developed country for its novel coronavirus (COVID-19) vaccine — over the price it's charging the United States under a contract signed last week — CEO Albert Bourla said at a conference call Tuesday.
The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved